Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 0.4% – What’s Next?

Shares of Universe Pharmaceuticals INC (NYSE:UPC) were down 0.4% during trading on Friday . The stock traded as low as $0.62 and last traded at $0.64. Approximately 594,071 shares were traded during trading, a decline of 7% from the average daily volume of 635,835 shares. The stock had previously closed at $0.64.

Universe Pharmaceuticals Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 1.63. The business’s 50 day simple moving average is $1.86 and its two-hundred day simple moving average is $23.06.

Institutional Investors Weigh In On Universe Pharmaceuticals

An institutional investor recently bought a new position in Universe Pharmaceuticals stock. MML Investors Services LLC bought a new stake in shares of Universe Pharmaceuticals INC (NYSE:UPC) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned about 6.46% of Universe Pharmaceuticals at the end of the most recent quarter. Hedge funds and other institutional investors own 0.18% of the company’s stock.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.